menu
    • menu

    Company profile for AqVida GmbH

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The company AqVida is a German pharmaceutical company specialized in the development, registration and distribution of finished dosage forms mainly in the oncology sector. We have developed a portfolio of anti-cancer medicines treating the most common types of cancer. Our core products are e.g. Paclitaxel, Oxaliplatin and Docetaxel. All manufacturing, analyzing and releasing processes of AqVida are GMP certified by the German ...
    The company AqVida is a German pharmaceutical company specialized in the development, registration and distribution of finished dosage forms mainly in the oncology sector. We have developed a portfolio of anti-cancer medicines treating the most common types of cancer. Our core products are e.g. Paclitaxel, Oxaliplatin and Docetaxel. All manufacturing, analyzing and releasing processes of AqVida are GMP certified by the German Authorities to meet the high quality standards of the European market.Depending on market conditions we license out under our partners' brands or market under the AqVida brand. Thus enabling us to reach a considerable market-share in Europe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AqVida GmbHGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Kaiser - Wilhelm-Str. 89
    D-20355 Hamburg
    Telephone
    Telephone
    +49 403 803 7190
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.aqvida.com
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
    AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation

    18 Apr 2019

    // PRESS RELEASE

    https://phytonbiotech.com/aqvida-and-phyton-biotech-receive-approval-from-european-directorate-of-quality-medicines-for-aqvidas-cancer-fighting-paclitaxel-injectable-finished-dosage-formulation/

    PRESS RELEASE
    18 Apr 2019
    Share Share
    Successful BE study paves way for AqVida to launch first generic Sunitinib capsules
    Successful BE study paves way for AqVida to launch first generic Sunitinib capsules

    23 May 2016

    // PRESS RELEASE

    https://www.pharmaceutical-networking.com/successful-be-study-paves-way-for-aqvida-to-launch-first-generic-sunitinib-capsules/

    PRESS RELEASE
    23 May 2016
    Share Share
    AqVida celebrates successful CPhI Madrid show
    AqVida celebrates successful CPhI Madrid show

    02 Nov 2015

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/aqvida-celebrates-successful-cphi-madrid-show-1446532980.pdf

    PRESS RELEASE
    02 Nov 2015
    Share Share
    AqVida crowns innovative first decade with robotic filling breakthrough
    AqVida crowns innovative first decade with robotic filling breakthrough

    23 Sep 2015

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/aqvida-crowns-innovative-first-decade-with-robotic-filling-breakthrough-1443001323.pdf

    PRESS RELEASE
    23 Sep 2015
    Share Share
    AqVida joins European generics pioneers with Sunitinib development
    AqVida joins European generics pioneers with Sunitinib development

    16 Aug 2015

    // Press Release AQVIDA GMBH

    https://www.pharmacompass.com/pdf/news/aqvida-joins-european-generics-pioneers-with-sunitinib-development-1441359468.pdf

    Press Release AQVIDA GMBH
    16 Aug 2015
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search